[ad_1] Novo Nordisk A/S is spending 15.9 billion Danish kroner ($2.29 billion) to expand production facilities in Denmark as the obesity drug manufacturer looks to ensure capacity for its future…
Tag: Lars Fruergaard Jorgensen
Ozempic Maker Novo Nordisk Invests $2.3 Billion in France Site
[ad_1] Novo Nordisk A/S plans to invest €2.1 billion ($2.3 billion) to expand production in France as it works to meet surging demand for its sought-after weight-loss medicines. The construction…